✦ LIBER ✦

Demonstration of a cross-reactive idiotype (idrq) in rheumatoid factors from patients with rheumatoid arthritis but not in rheumatoid factors from healthy, Aged subjects

✍ Scribed by Alejandro Ruiz-Arguelles; Miguel Presno-Bernal

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 483 KB
Volume: 32
Category: Article
ISSN: 0004-3591
DOI: 10.1002/anr.1780320204

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Normalization of A2A and A3 adenosine re

Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti–tumor necrosis factor α but not methotrexate

✍ Katia Varani; Alfonso Massara; Fabrizio Vincenzi; Alice Tosi; Melissa Padovan; F 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB 👁 2 views

Evidence of radiographic benefit of trea

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti–tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study

✍ J. S. Smolen; C. Han; M. Bala; R. N. Maini; J. R. Kalden; D. van der Heijde; F. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

Evaluation of the safety of rituximab in

Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: Results from a randomized controlled trial

✍ Maria W. Greenwald; William J. Shergy; Jeffrey L. Kaine; Marianne T. Sweetser; K 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views

Tumor necrosis factor receptor type II (

Tumor necrosis factor receptor type II (exon 6) and interleukin-6 (−174) gene polymorphisms are not associated with family history but tumor necrosis factor receptor type II is associated with hypertension in patients with rheumatoid arthritis from northern Sweden

✍ Solbritt Rantapää Dahlqvist; Lisbeth Ärlestig; Carin Sikström; Solveig Linghult 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

The comparative one-year performance of

The comparative one-year performance of anti–tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: Results from a longitudinal, observational, multicenter study

✍ Heiberg, Marte Schrumpf ;Koldingsnes, Wenche ;Mikkelsen, Knut ;Rødevand, Erik ;K 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Influence of anti–tumor necrosis factor

Influence of anti–tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register

✍ W. G. Dixon; K. D. Watson; M. Lunt; L. K. Mercer; British Society For Rheumatolo 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 111 KB 👁 2 views